Search research articles
Contact Us
Filters
Showing results (61-70 of 109) with videos related to
Page
of 11
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 30, 2023
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study
Carla Biesdorf, Xiaowen Guan, Satya R Siddani, et al.
Leukemia & Lymphoma
|
May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Oncotarget
|
October 13, 2016
Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients
Lene Sofie Granfeldt Østgård, Mette Nørgaard, Henrik Sengeløv, et al.
American Journal of Hematology
|
September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience
Holbrook E Kohrt, Samit Patel, Michelle Ho, et al.
Leukemia Research
|
September 29, 2009
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
Bruno C Medeiros, Holbrook E Kohrt, Daniel A Arber, et al.
Plos One
|
July 11, 2019
Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
Rupa Narayan, Niclas Olsson, Lisa E Wagar, et al.
American Journal of Hematology
|
June 26, 2012
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia
Di Sun, Paul Elson, Michaela Liedtke, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
Leukemia Research
|
January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)
Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Haematologica
|
December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Daniel A Pollyea, James Zehnder, Steve Coutre, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 109) with videos related to
Sort By:
Page
of 11
Cancer Chemotherapy and Pharmacology
|
November 30, 2023
Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study
Carla Biesdorf, Xiaowen Guan, Satya R Siddani, et al.
Leukemia & Lymphoma
|
May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Oncotarget
|
October 13, 2016
Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients
Lene Sofie Granfeldt Østgård, Mette Nørgaard, Henrik Sengeløv, et al.
American Journal of Hematology
|
September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience
Holbrook E Kohrt, Samit Patel, Michelle Ho, et al.
Leukemia Research
|
September 29, 2009
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)
Bruno C Medeiros, Holbrook E Kohrt, Daniel A Arber, et al.
Plos One
|
July 11, 2019
Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
Rupa Narayan, Niclas Olsson, Lisa E Wagar, et al.
American Journal of Hematology
|
June 26, 2012
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia
Di Sun, Paul Elson, Michaela Liedtke, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
Leukemia Research
|
January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)
Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Haematologica
|
December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Daniel A Pollyea, James Zehnder, Steve Coutre, et al.
Page
of 11